The analysis of homologous recombination DNA repair in primary breast and ovarian tumours in patients with pathogenic germline variants in…
Hereditary Cancer Genetics Group
The Breast Cancer Research Foundation (BCRF) will commit $60.2 million to breast cancer research in 2023-2024, supporting more than 250…
An International Workgroup of Cancer Genetics Experts Convened by the American College of Medical Genetics and Genomics Develops Guidance on…
The RADPrecise project young investigators team, coordinated by Ester Aguado Flor from the VHIO Hereditary Cancer Genetics Group, has won…
Recently published in the Journal of Medical Genetics* results of a case-control study spearheaded by VHIO’s Judith Balmaña show that…
Barcelona, August 02, 2021. The BRCA1 and BRCA2 genes are crucial actors in the DNA damage response and repair pathway;…
ASCO Plenary: PARPi prevents disease recurrence in BRCA-mutated high-risk, early stage breast cancer
Full results from the OlympiA Phase III, multicenter trial promise to extend the use of PARPi olaparib as adjuvant therapy…
In parallel with the European Society for Medical Oncology’s (ESMO) publication of its 2025 Vision, which builds on the core…
